🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
REMoxTB is a study for the "Rapid Evaluation of Moxifloxacin in the treatme...
Status
Completed
Location
Beijing Tuberculosis and Thoracic Tumor Research Institute
Start Date
2008-01
Trial ID
NCT00864383
Treatments Being Tested
Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Status
Recruiting
Location
National Tuberculosis Reference Laboratory
Start Date
2024-01-03
Trial ID
NCT06199921
The purpose of this study is to assess pharmacokinetic parameters of atorva...
Status
Recruiting
Location
National Tuberculosis and Leprosy Training Centre, Saye
Start Date
2026-01-03
Trial ID
NCT07303699
The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Active Not Recruiting
Location
Beijing Chest Hospital affiliated to Capital Medical University
Start Date
2023-12-22
Trial ID
NCT06081361
The 4-month daily regimen containing moxifloxacin (2HRZEM 7 / 2HRM7) of ICM...
Status
Unknown
Location
National Institute for Research in Tuberculosis
Start Date
2022-03-15
Trial ID
NCT05047055
Treatments Being Tested
Tuberculosis meningitis (TBM) is the most severe manifestation of TB, resul...
Status
Completed
Location
Hasan Sadikin General Hospital
Start Date
2021-06-21
Trial ID
NCT03537495
Treatments Being Tested
The purpose of this study was to compare a 3-month rifapentine (RPT)/clofaz...
Status
Terminated
Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
Start Date
2021-11-05
Trial ID
NCT04311502
To evaluate the non-inferiority in efficacy between the rifapentine- and mo...
Status
Not Yet Recruiting
Location
Shandong Public Health Clinical Center
Start Date
2025-04-05
Trial ID
NCT06917495
Treatments Being Tested
The purpose of this study is to determine whether one or two four-month reg...
Status
Completed
Location
TBTC Site 82/ ACTG Site 801 USCF AIDS CRS
Start Date
2016-01-25
Trial ID
NCT02410772
Treatments Being Tested
This trial will evaluate the safety, tolerability, pharmacokinetics (PK), a...
Status
Completed
Location
University of Cape Town (Pty) Ltd.
Start Date
2018-10-18
Trial ID
NCT03678688